New Lab Approach Identifies Early-Stage Insulin Resistance, a Precursor to Prediabetes and Type 2 Diabetes, Finds Study in Journal of Endocrine Society

Innovation

A novel laboratory method can aid the identification of insulin resistance (IR), a precursor to prediabetes and type 2 diabetes, according to a study published in Journal of the Endocrine Society.

A Dangerous Pattern: High Rates of Drug Combining to be Revealed by Quest Diagnostics at 2018 AAFP Conference

Insights

The American Academy of Family Physicians (AAFP) conference is an annual event that explores family medicine from all angles. This year’s meeting – October 9-13 in New Orleans – will gather over 4,000 physicians from across the country to share best practices and learn from each other. Among the topics to be a major area of […]

Quest Diagnostics Collaborates with Leading Physicians in Hereditary Cancer Study

Insights

Quest Diagnostics, Inc. is the exclusive genetic-testing partner for the BRCA Founder Outreach Study (BFOR), which offers BRCA testing to 4,000 Ashkenazi-Jewish men and women in four major metropolitan U.S. cities: New York, Los Angeles, Philadelphia, and Boston.  One of the BFOR Study’s main goals is to explore new ways our healthcare system can use genetic testing […]

Cytogenetic Analysis in Chronic Lymphocytic Leukemia (CLL): The Rediscovered Value of Metaphase Chromosome Analysis

Insights

B-cell chronic lymphocytic leukemia (CLL) is the most common adult leukemia in the western world, and has a highly variable clinical course, ranging from indolent to highly aggressive.